Skip to main content
  1. Home
  2. Emerging Tech
  3. Outdoors
  4. News

Digital Trends may earn a commission when you buy through links on our site. Why trust us?

Juiced Bikes sold at auction for $1.2 million, report says

Add as a preferred source on Google
The Juiced Bikes Scorpion X2 adds more power, upgraded tires, and an improved battery to the popular moped style e-bike.
Juiced Bikes

Juiced Bikes, the San Diego-based maker of e-bikes, has been sold on an auction website for $1,225,000, according to a report from Electrek.

Digital Trends recently reported how the company was showing signs of being on the brink of bankruptcy. The company and its executives had remained silent, while customer inquiries went unanswered and its website showed all products were out of stock. In addition, there were numerous reports of layoffs at the company.

Yet, the most convincing sign was that the company’s assets appeared as listed for sale on an auction website used by companies that go out of business.

Now, it appears that Juiced Bikes’ assets, including a dozen patents, multiple URLs, and the company’s inventory in both the U.S. and China, have been sold at auction, according to the report.

It is likely that the buyer, who remains unknown, can capitalize on the brand and the overall value of the 15-year old company.

Founded in 2009 by Tora Harris, a U.S. high-jump Olympian, Juiced Bikes was one of the early pioneers of the direct-to-consumer e-bike brands in the U.S. market.

The company had quickly built a reputation for the versatility of its e-bikes and the durability of their batteries. Over the years, the popularity of models such as the CrossCurrent, HyperScrambler, and RipCurrent only bolstered the brand’s status.

Last year, Digital Trends named the Juiced Bikes Scorpion X2 as the best moped-style e-bike for 2023, citing its versatility, rich feature set, and performance.

Juiced Bikes’ getting sold quickly might be a sign of what consulting firm Houlihan Lokey says is a recovery in the North American e-bike market.

Recommended Videos

The industry has had a roller-coaster ride during and after the COVID-19 pandemic: A huge spike in demand for e-bikes had combined with disrupted supply chains to create a supply/demand mismatch of “historic proportions,” Houlihan Lokey said.

Nick Godt
Former Freelance reporter
Nick Godt has covered global business news on three continents for over 25 years.
Students who use AI every day may be falling behind, while moderate users pull ahead
New global testing data suggests more AI in the classroom isn't automatically better.
Logo, Text

I assumed more AI access might help students learn faster. However, a new OECD study dispels that misconception for me and everyone else who gave their children a paid version of AI chatbots, thinking it would help them through their educational journey. 

According to PISA 2025 data from 760,000 students in 91 countries, students who use AI daily score meaningfully worse on standardized tests than their peers. The full picture is more complicated than a simple ban would fix.

Read more
XPENG just put its humanoid robot on the production line, and it walked itself out
IRON clocks in for its first shift
XPENG Iron

XPENG’s humanoid robot has officially joined the workforce, and it even got an employee badge. The Chinese automaker announced on September 8 that its next-generation IRON had completed assembly and autonomously walked off its newly commissioned humanoid robot production line in Guangzhou.

CEO He Xiaopeng then pinned a staff badge onto the robot, symbolically welcoming it to the XPENG team. It is a charming little ceremony for a machine that the company hopes will eventually become a regular part of everyday life. XPENG is moving IRON beyond R&D prototypes toward production-line manufacturing, applying the quality-control systems and manufacturing experience it has developed through its electric vehicle business.

Read more
An AI-designed drug might help slow aging, but we’re not there yet
The results hint at a possible anti-aging effect, but there’s still a long way to go before we know what it means.
medical test tubes

Rentosertib, a drug Insilico Medicine designed almost entirely using AI, was created to treat idiopathic pulmonary fibrosis, a disease that scars and stiffens the lungs over time. But fighting lung disease was only half the plan from the start.

According to a new study published in Nature Biotechnology, the drug's target was chosen specifically because it overlaps heavily with the biology of aging, and the whole trial was designed to test whether treating the lungs could also mean turning back the body's biological clock.

Read more